1887
banner image
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.
f
The adoption of new technology in radiation oncology should rely on evidence-based medicine
Rent:
Rent this article for
Access full text Article
/content/aapm/journal/medphys/38/6/10.1118/1.3533903
1.
1. K. J. Bozic, R. G. Pierce, and J. H. Herndon. “Health care technology assessment. Basic principles and clinical applications,” J. Bone Joint Surg. 86, 13051314 (2004).
2.
2. D. L. Sackett et al. , “Evidence based medicine: What it is and what it isn’t,” Brit. Med. J. 312, 7172 (1996).
3.
3. E. Tanjong-Ghogomuy, P. Tugwell, and V. Welch, “Evidence-based medicine and the Cochrane Collaboration,” Bull. NYU Hosp. Joint Dis. 67, 198205 (2009).
4.
4. B. Fisher et al. , “Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer.N. Engl. J. Med. 312, 665673 (1985).
http://dx.doi.org/10.1056/NEJM198503143121101
5.
5. G. W. Stone et al. , “Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: The TAXUS V ISR randomized trial,” J. Am. Med. Assoc. 295, 12531263 (2006).
http://dx.doi.org/10.1001/jama.295.11.1253
6.
6. H. P. Soares et al. , “Evaluation of new treatments in radiation oncology: Are they better than standard treatments?,” J. Am. Med. Assoc. 293, 970978 (2005).
http://dx.doi.org/10.1001/jama.293.8.970
7.
7. C. Borger et al. , “Health spending projections through 2015: Changes on the horizon,” Health Aff. 25, 6173 (2006).
http://dx.doi.org/10.1377/hlthaff.25.w61
8.
8. The Kaiser Family Foundation, “Health care costs: A primer,” See: http://www.kff.org/insurance/7670.cfm, Last accessed 2009.
9.
9. S. Timmermans and A. Mauck, “The promises and pitfalls of evidence-based medicine,” Health Aff. 24, 1828 (2005).
http://dx.doi.org/10.1377/hlthaff.24.1.18
10.
10. U.S. Preventative Services Task Force, Guide to Clinical Preventive Services (Diane Publishing Co., Darby, PA, 1989).
11.
11. S. M. Bentzen, “Randomized controlled trials in health technology assessment: Overkill or overdue?,” Radiother. Oncol. 86, 142147 (2008).
http://dx.doi.org/10.1016/j.radonc.2008.01.012
12.
12. B. Glimelius and A. Montelius, “Do we need the randomized trials and can we do them?,” Radiother. Oncol. 83, 105109 (2007).
http://dx.doi.org/10.1016/j.radonc.2007.04.009
13.
13. S. M. Bentzen, “Towards evidence based radiation oncology: Improving the design, analysis, and reporting of clinical outcome studies in radiotherapy,” Radiother. Oncol. 46, 518(1998).
http://dx.doi.org/10.1016/S0167-8140(97)00226-0
14.
14. M. H. Ebell et al. , “Strength of recommendation taxonomy (SORT): A patient-centered approach to grading evidence in the medical literature,” Am. Fam. Physician, 69, 548556 (2004).
15.
15. J. L. Brozek et al. , “Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions,” Allergy 64, 669677 (2009).
http://dx.doi.org/10.1111/j.1398-9995.2009.01973.x
16.
16. S. S. Dhruva, L. A. Bero, and R. F. Redberg, “Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices,” J. Am. Med. Assoc. 302, 26792685 (2009).
http://dx.doi.org/10.1001/jama.2009.1899
17.
17. N. J. Meropol, “A renewed call for equipoise,” J. Clin. Oncol. 25, 33923394 (2007).
http://dx.doi.org/10.1200/JCO.2007.11.9503
18.
18. B. Djulbegovic, “The paradox of equipoise: The principle that drives and limits therapeutic discoveries in clinical research,” Cancer Control 16, 342347 (2009).
19.
19. E. C. Halperin, “Randomized prospective trials of innovative radiotherapy technology are necessary,” J. Am. Coll. Radiol. 6, 3337 (2009).
http://dx.doi.org/10.1016/j.jacr.2008.07.011
20.
20. R. Jackson and G. Feder, “Guidelines for clinical guidelines,” Brit. Med. J. 317, 427428 (1998).
http://aip.metastore.ingenta.com/content/aapm/journal/medphys/38/6/10.1118/1.3533903
Loading
/content/aapm/journal/medphys/38/6/10.1118/1.3533903
Loading

Data & Media loading...

Loading

Article metrics loading...

/content/aapm/journal/medphys/38/6/10.1118/1.3533903
2011-05-20
2014-10-23

Abstract

There is no abstract available for this article.

Loading

Full text loading...

/deliver/fulltext/aapm/journal/medphys/38/6/1.3533903.html;jsessionid=21nj6bxd3vemv.x-aip-live-02?itemId=/content/aapm/journal/medphys/38/6/10.1118/1.3533903&mimeType=html&fmt=ahah&containerItemId=content/aapm/journal/medphys
true
true
This is a required field
Please enter a valid email address
752b84549af89a08dbdd7fdb8b9568b5 journal.articlezxybnytfddd
Scitation: The adoption of new technology in radiation oncology should rely on evidence-based medicine
http://aip.metastore.ingenta.com/content/aapm/journal/medphys/38/6/10.1118/1.3533903
10.1118/1.3533903
SEARCH_EXPAND_ITEM